Improved Safety of New MicroRNA-Regulated Oncolytic Coxsackievirus B3 Observed After Intravenous Administration in Colorectal-Tumor-Bearing Mice
Viruses · 2026
DOI: 10.3390/v18010143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2026. Verfasst von Leslie Elsner und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biochemistry, Institute of Biotechnology, Technische Universität Berlin, 13355 Berlin, Germany. Hauptthemen laut MEDLINE: MicroRNAs, Oncolytic Viruses, Colorectal Neoplasms, Enterovirus B, Human. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, German Cancer Aid, Wilhelm Sander Stiftung.
Abstract (Originalsprache)
Oncolytic coxsackievirus B3 (oCVB3) strain PD-H has shown potent oncolytic efficacy and a remarkable safety profile in the treatment of colorectal cancer in vivo after intratumoral (i.t.) injection. In this study, we investigated the safety and efficiency of PD-H following intravenous (i.v.) virus administration. When injected i.v. into Balb/C mice bearing subcutaneous Colon-26 tumors, PD-H led to slightly reduced tumor progression and a significant increase in animal survival, but it also caused multi-organ infection and tissue damage. To improve the safety profile of PD-H, we inserted microRNA target sites (miR-TS) of the heart-specific miR-1, pancreas-specific miR-375, liver-specific miR-122, and brain-specific miR-124 or the tumor-suppressor miR-145 into the genome of PD-H and generated the viruses PD-622TS and PD-145TS. Both viruses replicated similarly and induced cytotoxicity comparable to that of PD-H in the colorectal carcinoma cell lines Colon-26 and CT-26Luc. Their replication was inhibited in HEK293T cells transiently transfected with the cognate microRNAs. In vivo, i.v. administration of PD-145TS and PD-622TS to healthy Balb/C mouse resulted in significantly lower viral titers in the organs of mice and led to significantly less-intense pathological alterations compared to PD-H. PD-622TS injected i.v. into Balb/C mice with CT-26Luc-induced peritoneal carcinomatosis did not induce off-target alterations in normal organs, but it failed to induce a therapeutic effect. These data indicate that PD-H or microRNA-regulated PD derivatives exhibit only limited therapeutic efficacy following i.v. injection in colorectal tumor-bearing mice. However, the newly engineered microRNA-regulated PD-H variants demonstrate improved safety profiles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Biochemistry, Institute of Biotechnology, Technische Universität Berlin, 13355 Berlin, Germany.
- Institute of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.
- Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.
- Cardiopathology, Institute for Pathology and Neuropathology, University Hospital Tuebingen, 72076 Tuebingen, Germany.
- Berlin Institute of Health Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum (CVK), Föhrer Str. 15, 13353 Berlin, Germany.
- German Center for Cardiovascular Research (DZHK), Partner Site Berlin-Charité, Oudenarder Straße 16, 13316 Berlin, Germany.
ORCID-Profile: Leslie Elsner, Ahmet Hazini, Anja Geisler, Karin Klingel, Sophie Van Linthout, Jens Kurreck, Robert Klopfleisch, Henry Fechner
Förderung
- Deutsche Forschungsgemeinschaft
- German Cancer Aid
- Wilhelm Sander Stiftung
- Deutsche Krebshilfe
- Willhelm Sander-Stiftung
Zitieren
APA
Elsner, L., Hinze, L., Hazini, A., Heimann, L., Geisler, A., Dieringer, B., Klingel, K., Linthout, S. V., Kurreck, J., Klopfleisch, R., & Fechner, H. (2026). Improved Safety of New MicroRNA-Regulated Oncolytic Coxsackievirus B3 Observed After Intravenous Administration in Colorectal-Tumor-Bearing Mice. Viruses. https://doi.org/10.3390/v18010143
Vancouver
Elsner L, Hinze L, Hazini A, Heimann L, Geisler A, Dieringer B, et al. Improved Safety of New MicroRNA-Regulated Oncolytic Coxsackievirus B3 Observed After Intravenous Administration in Colorectal-Tumor-Bearing Mice. Viruses. 2026. doi:10.3390/v18010143
BibTeX
@article{Elsner2026,
author = {Elsner, Leslie and Hinze, Luisa and Hazini, Ahmet and Heimann, Lisanne and Geisler, Anja and Dieringer, Babette and Klingel, Karin and Linthout, Sophie Van and Kurreck, Jens and Klopfleisch, Robert and Fechner, Henry},
title = {Improved Safety of New MicroRNA-Regulated Oncolytic Coxsackievirus B3 Observed After Intravenous Administration in Colorectal-Tumor-Bearing Mice},
journal = {Viruses},
year = {2026},
doi = {10.3390/v18010143}
}
EUVIMED